The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint dataVictor J. Dzau, Michael A. Weber, Kenneth E. Bernstein et al.|The American Journal of Cardiology|2001Cited by 260
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Salim Yusuf, Lisheng Liu et al.|The Lancet|2021Cited by 148
Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus ReportVictor J. Dzau, Michael Weber, Kenneth E. Bernstein et al.|Cardiovascular Drugs and Therapy|2002Cited by 133
Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Brett R. Cowan, Garry Jennings, Alistair A. Young et al.|The American Journal of Cardiology|2009Cited by 47